Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2012

01.09.2012 | Breast Oncology

Use of Magnetic Resonance Imaging in Detection of Breast Cancer Recurrence: A Systematic Review

verfasst von: Edel Marie Quinn, MB, BAO, BCh, BMedSc, MRCSI, Andrew Peter Coveney, LRCP, SI, MB, BCh, MRCSI, Henry Paul Redmond, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Diagnosis of breast cancer recurrence can be difficult as a result of the presence of scar tissue in the breast. Magnetic resonance imaging (MRI) may be superior to traditional imaging in diagnosis of recurrence because of its ability to differentiate malignancy from scarring. Current guidelines on investigation of suspected breast cancer recurrence recommend MRI when other investigations have equivocal findings. We performed the first systematic review on this topic.

Methods

Literature search revealed 35 potentially relevant studies; 10 were included in final analysis. Included were clinical studies comparing MRI with another diagnostic modality for diagnosis of breast cancer recurrence, with at least 10 patients, in the English language. Data extraction focused on sensitivity and specificity of standard diagnostic modalities and MRI for diagnosis of local disease recurrence.

Results

In total 494 patients were assessed across 10 studies; all were case series. Sensitivity of MRI for detection of recurrence ranged 75–100 %, while specificity ranged 66.6–100 %. Both sensitivity and specificity increased when MRI was performed after a longer time interval from the original surgery, although the longest follow-up reported was only 36 months. A negative MRI can avoid the need for further biopsy.

Conclusions

Available data are based on clinically heterogeneous case series and superiority over standard triple assessment for breast cancer recurrence has not been proven. At present, MRI cannot be recommended in the routine diagnostic assessment for breast cancer recurrence but has a potentially useful role as a second-line investigation. A negative MRI is more useful than a positive MRI as positive MRIs require further investigation.
Literatur
1.
Zurück zum Zitat Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46:1296–316.PubMedCrossRef Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46:1296–316.PubMedCrossRef
2.
Zurück zum Zitat National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment. Cardiff, Wales: National Collaborating Centre for Cancer; 2009. National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment. Cardiff, Wales: National Collaborating Centre for Cancer; 2009.
3.
Zurück zum Zitat Kimura M, Yanagita Y, Fujisawa T, Koida T. Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery. Breast Cancer Res Treat. 2007;106:407–11.PubMedCrossRef Kimura M, Yanagita Y, Fujisawa T, Koida T. Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery. Breast Cancer Res Treat. 2007;106:407–11.PubMedCrossRef
4.
Zurück zum Zitat Mendelson EB. Evaluation of the postoperative breast. Radiol Clin North Am. 1992;30:107–38.PubMed Mendelson EB. Evaluation of the postoperative breast. Radiol Clin North Am. 1992;30:107–38.PubMed
5.
Zurück zum Zitat Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol. 1991;43:197–204.PubMedCrossRef Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol. 1991;43:197–204.PubMedCrossRef
6.
Zurück zum Zitat Preda L, Villa G, Rizzo S, et al. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res. 2006;8:R53.PubMedCrossRef Preda L, Villa G, Rizzo S, et al. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res. 2006;8:R53.PubMedCrossRef
7.
Zurück zum Zitat Belli P, Costantini M, Romani M, Marano P, Pastore G. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat. 2002;73:223–35.PubMedCrossRef Belli P, Costantini M, Romani M, Marano P, Pastore G. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat. 2002;73:223–35.PubMedCrossRef
8.
Zurück zum Zitat Kerslake RW, Fox JN, Carleton PJ, et al. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. Br J Radiol. 1994;67:1158–68.PubMedCrossRef Kerslake RW, Fox JN, Carleton PJ, et al. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. Br J Radiol. 1994;67:1158–68.PubMedCrossRef
9.
Zurück zum Zitat Viehweg P, Heinig A, Lampe D, Buchmann J, Heywang-Kobrunner SH. Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA. 1998;7:141–52.PubMedCrossRef Viehweg P, Heinig A, Lampe D, Buchmann J, Heywang-Kobrunner SH. Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA. 1998;7:141–52.PubMedCrossRef
10.
Zurück zum Zitat Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375(9714):563–71.PubMedCrossRef Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375(9714):563–71.PubMedCrossRef
11.
Zurück zum Zitat Houssami N, Hayes D. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290–302.PubMedCrossRef Houssami N, Hayes D. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290–302.PubMedCrossRef
12.
Zurück zum Zitat Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate and margin status. J Am Coll Surg. 2009;209:180–7.PubMedCrossRef Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate and margin status. J Am Coll Surg. 2009;209:180–7.PubMedCrossRef
13.
Zurück zum Zitat Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.PubMedCrossRef Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.PubMedCrossRef
14.
Zurück zum Zitat Cohen EK, Leonhardt CM, Shumak RS, et al. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations. Can Assoc Radiol J. 1996;47:171–6.PubMed Cohen EK, Leonhardt CM, Shumak RS, et al. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations. Can Assoc Radiol J. 1996;47:171–6.PubMed
15.
Zurück zum Zitat Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology. 1993;177:473–8. Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology. 1993;177:473–8.
16.
Zurück zum Zitat Goerres GW, Michel SC, Fehr MK, et al. Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol. 2003;12:1635–44.CrossRef Goerres GW, Michel SC, Fehr MK, et al. Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol. 2003;12:1635–44.CrossRef
17.
Zurück zum Zitat Kramer S, Schulz-Wendtland R, Hagedorn K, Bautz W, Lang N. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res. 1998;18:2159–62.PubMed Kramer S, Schulz-Wendtland R, Hagedorn K, Bautz W, Lang N. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res. 1998;18:2159–62.PubMed
18.
Zurück zum Zitat Mumtaz H, Davidson T, Hall-Craggs MA, et al. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg. 1997;84:1147–51.PubMedCrossRef Mumtaz H, Davidson T, Hall-Craggs MA, et al. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg. 1997;84:1147–51.PubMedCrossRef
19.
Zurück zum Zitat Rieber A, Merkle E, Zeitler H, et al. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr. 1997;21:780–4.PubMedCrossRef Rieber A, Merkle E, Zeitler H, et al. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr. 1997;21:780–4.PubMedCrossRef
20.
Zurück zum Zitat Dao TH, Rahmouni A, Campana F, Laurfent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium enhanced MR imaging. Radiology. 1993;187:751–5.PubMed Dao TH, Rahmouni A, Campana F, Laurfent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium enhanced MR imaging. Radiology. 1993;187:751–5.PubMed
22.
Zurück zum Zitat Drew PJ, Kerin MJ, Turnbull LW, et al. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol. 1998;5:265–70.PubMedCrossRef Drew PJ, Kerin MJ, Turnbull LW, et al. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol. 1998;5:265–70.PubMedCrossRef
23.
Zurück zum Zitat Daly CP, Jaeger B, Sill DS. Variable appearances of fat necrosis on breast MRI. AJR Am J Roentgenol. 2008;191:1374–80.PubMedCrossRef Daly CP, Jaeger B, Sill DS. Variable appearances of fat necrosis on breast MRI. AJR Am J Roentgenol. 2008;191:1374–80.PubMedCrossRef
24.
Zurück zum Zitat Ganau S, Tortjada L, Escribano F, Andreu X, Sentis M. The great mimicker: fat necrosis of the breast—magnetic resonance mammography approach. Curr Probl Diagn Radiol. 2009;38:189–97.PubMedCrossRef Ganau S, Tortjada L, Escribano F, Andreu X, Sentis M. The great mimicker: fat necrosis of the breast—magnetic resonance mammography approach. Curr Probl Diagn Radiol. 2009;38:189–97.PubMedCrossRef
25.
Zurück zum Zitat Li J, Dershaw DD, Lee CF, Joo S, Morris EA. Breast MRI after conservation therapy: usual findings in routine follow-up examinations. AJR Am J Roentgenol. 2010;195:799–807.PubMedCrossRef Li J, Dershaw DD, Lee CF, Joo S, Morris EA. Breast MRI after conservation therapy: usual findings in routine follow-up examinations. AJR Am J Roentgenol. 2010;195:799–807.PubMedCrossRef
26.
Zurück zum Zitat Ojeda-Fournier H, Olson LK, Rochelle M, Hodgens BD, Tong E, Yashar CM. Accelerated partial breast irradiation and posttreatment imaging evaluation. Radiographics. 2011;31:1701–16.PubMedCrossRef Ojeda-Fournier H, Olson LK, Rochelle M, Hodgens BD, Tong E, Yashar CM. Accelerated partial breast irradiation and posttreatment imaging evaluation. Radiographics. 2011;31:1701–16.PubMedCrossRef
27.
Zurück zum Zitat Cilotti A, Iacconi C, Marini C, et al. Contrast-enahnced MR imaging in patients with BI-RADS 3–5 microcalcifications. Radiol Med. 2007;112:272–86.PubMedCrossRef Cilotti A, Iacconi C, Marini C, et al. Contrast-enahnced MR imaging in patients with BI-RADS 3–5 microcalcifications. Radiol Med. 2007;112:272–86.PubMedCrossRef
28.
Zurück zum Zitat Uematsu T, Yuen S, Kasami M, Uchida Y. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Breast Cancer Res Treat. 2007;103:269–81.PubMedCrossRef Uematsu T, Yuen S, Kasami M, Uchida Y. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Breast Cancer Res Treat. 2007;103:269–81.PubMedCrossRef
29.
Zurück zum Zitat Fiaschetti V, Pistolese CA, Perretta T, et al. 3–5 BI-RADs microcalcifications: correlation between MRI and histological findings. ISRN Oncol. 2011;2011:643890. Fiaschetti V, Pistolese CA, Perretta T, et al. 3–5 BI-RADs microcalcifications: correlation between MRI and histological findings. ISRN Oncol. 2011;2011:643890.
30.
Zurück zum Zitat Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—Randomised controlled trial. Eur J Cancer. 2011;47:879–86.PubMedCrossRef Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—Randomised controlled trial. Eur J Cancer. 2011;47:879–86.PubMedCrossRef
31.
Zurück zum Zitat American College of Radiology. Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 1998. American College of Radiology. Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 1998.
Metadaten
Titel
Use of Magnetic Resonance Imaging in Detection of Breast Cancer Recurrence: A Systematic Review
verfasst von
Edel Marie Quinn, MB, BAO, BCh, BMedSc, MRCSI
Andrew Peter Coveney, LRCP, SI, MB, BCh, MRCSI
Henry Paul Redmond, FRCS
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2341-3

Weitere Artikel der Ausgabe 9/2012

Annals of Surgical Oncology 9/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.